<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-03-21" modified="2020-10-07" version="161">
<accession>O15446</accession>
<accession>Q32N11</accession>
<accession>Q7Z5U2</accession>
<accession>Q9UPF6</accession>
<name>RPA34_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="22">DNA-directed RNA polymerase I subunit RPA34</fullName>
</recommendedName>
<alternativeName>
<fullName>A34.5</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="21">Antisense to ERCC-1 protein</fullName>
<shortName evidence="21">ASE-1</shortName>
</alternativeName>
<alternativeName>
<fullName evidence="19">CD3-epsilon-associated protein</fullName>
<shortName evidence="19">CD3E-associated protein</shortName>
</alternativeName>
<alternativeName>
<fullName evidence="24">DNA-directed RNA polymerase I subunit G</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="23">RNA polymerase I-associated factor PAF49</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="24">POLR1G</name>
<name type="synonym" evidence="21">ASE1</name>
<name type="synonym" evidence="19">CAST</name>
<name type="synonym" evidence="24">CD3EAP</name>
<name type="synonym" evidence="20">PAF49</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Chromosoma" volume="106" first="493" last="502">
<title>ASE-1: a novel protein of the fibrillar centres of the nucleolus and nucleolus organizer region of mitotic chromosomes.</title>
<authorList>
<person name="Whitehead C.M."/>
<person name="Winkfein R.J."/>
<person name="Fritzler M.J."/>
<person name="Rattner J.B."/>
</authorList>
<dbReference type="PubMed" id="9426281"/>
<dbReference type="DOI" id="10.1007/s004120050271"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<source>
<tissue>Serum</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="18173" last="18180">
<title>CAST, a novel CD3epsilon-binding protein transducing activation signal for interleukin-2 production in T cells.</title>
<authorList>
<person name="Yamazaki T."/>
<person name="Hamano Y."/>
<person name="Tashiro H."/>
<person name="Itoh K."/>
<person name="Nakano H."/>
<person name="Miyatake S."/>
<person name="Saito T."/>
</authorList>
<dbReference type="PubMed" id="10373416"/>
<dbReference type="DOI" id="10.1074/jbc.274.26.18173"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>FUNCTION IN T-CELL RECEPTOR SIGNALING</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH CD3E</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT LYS-504</scope>
<source>
<tissue>Skin</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="5436" last="5448">
<title>RNA polymerase I-specific subunit CAST/hPAF49 has a role in the activation of transcription by upstream binding factor.</title>
<authorList>
<person name="Panov K.I."/>
<person name="Panova T.B."/>
<person name="Gadal O."/>
<person name="Nishiyama K."/>
<person name="Saito T."/>
<person name="Russell J."/>
<person name="Zomerdijk J.C.B.M."/>
</authorList>
<dbReference type="PubMed" id="16809778"/>
<dbReference type="DOI" id="10.1128/mcb.00230-06"/>
</citation>
<scope>IDENTIFICATION IN THE RNA POL I COMPLEX</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TAF1A AND UBTF</scope>
<scope>PHOSPHORYLATION AT TYR-80</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-309</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; SER-128; SER-136; SER-172; SER-205; SER-285 AND THR-287</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-136 AND SER-490</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-172 AND SER-285</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-136</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-128; SER-136; SER-172; SER-285 AND THR-287</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-270 AND LYS-314</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-270 AND LYS-314</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-270</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-270 AND LYS-314</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-270 AND LYS-314</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<comment type="function">
<text>DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Component of RNA polymerase I which synthesizes ribosomal RNA precursors. Isoform 1 is involved in UBTF-activated transcription, presumably at a step following PIC formation.</text>
</comment>
<comment type="function">
<text>Isoform 2 has been described as a component of preformed T-cell receptor (TCR) complex.</text>
</comment>
<comment type="subunit">
<text evidence="14 15 17">Component of the RNA polymerase I (Pol I) complex consisting of at least 13 subunits. Interacts with TAF1A thereby associates with the SL1 complex. Interacts with UBTF. Interacts with POLR1E/PRAF1 through its N-terminal region (By similarity). Isoform 2 interacts with CD3E.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="18">Nucleus</location>
<location evidence="18">Nucleolus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="18">Chromosome</location>
</subcellularLocation>
<text>Found at the fibrillar centers of the nucleolus in interphase and during cell division it is localized to the nucleolus organizer regions of the chromosomes.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O15446-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O15446-2</id>
<name>2</name>
<name>CAST</name>
<sequence type="described" ref="VSP_017673"/>
</isoform>
</comment>
<comment type="PTM">
<text>Isoform 2 undergoes tyrosine phosphorylation upon T-cell receptor (TCR) stimulation. This phosphorylation has not been confirmed by other groups.</text>
</comment>
<comment type="PTM">
<text>Isoform 1 is phosphorylated on tyrosine residues in initiation-competent Pol I-beta complexes but not in Pol I-alpha complexes.</text>
</comment>
<comment type="miscellaneous">
<text>It is in an antisense orientation to and overlaps the gene of the DNA repair enzyme ERCC1. This gene overlap is conserved in mouse, suggesting an important biological function.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 2</molecule>
<text evidence="22">Has sharply different functional characteristics.</text>
</comment>
<comment type="similarity">
<text evidence="22">Belongs to the eukaryotic RPA34 RNA polymerase subunit family.</text>
</comment>
<comment type="caution">
<text evidence="22">It is not known whether the so-called human ASE1 and human CAST proteins represent two sides of a single gene product with sharply different functional characteristics. Experiments done with the mouse homolog protein are in favor of an implication of this gene in rRNA transcription instead of T-cell receptor signaling.</text>
</comment>
<dbReference type="EMBL" id="U86751">
<property type="protein sequence ID" value="AAB68608.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF017633">
<property type="protein sequence ID" value="AAD41158.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC038992">
<property type="protein sequence ID" value="AAH38992.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC054044">
<property type="protein sequence ID" value="AAH54044.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC108889">
<property type="protein sequence ID" value="AAI08890.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12661.1">
<molecule id="O15446-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS74397.1">
<molecule id="O15446-2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001284519.1">
<molecule id="O15446-2"/>
<property type="nucleotide sequence ID" value="NM_001297590.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_036231.1">
<molecule id="O15446-1"/>
<property type="nucleotide sequence ID" value="NM_012099.1"/>
</dbReference>
<dbReference type="SMR" id="O15446"/>
<dbReference type="BioGRID" id="116060">
<property type="interactions" value="37"/>
</dbReference>
<dbReference type="CORUM" id="O15446"/>
<dbReference type="DIP" id="DIP-27616N"/>
<dbReference type="IntAct" id="O15446">
<property type="interactions" value="21"/>
</dbReference>
<dbReference type="MINT" id="O15446"/>
<dbReference type="STRING" id="9606.ENSP00000465099"/>
<dbReference type="iPTMnet" id="O15446"/>
<dbReference type="MetOSite" id="O15446"/>
<dbReference type="PhosphoSitePlus" id="O15446"/>
<dbReference type="BioMuta" id="CD3EAP"/>
<dbReference type="CPTAC" id="CPTAC-920"/>
<dbReference type="CPTAC" id="CPTAC-921"/>
<dbReference type="EPD" id="O15446"/>
<dbReference type="jPOST" id="O15446"/>
<dbReference type="MassIVE" id="O15446"/>
<dbReference type="MaxQB" id="O15446"/>
<dbReference type="PaxDb" id="O15446"/>
<dbReference type="PeptideAtlas" id="O15446"/>
<dbReference type="PRIDE" id="O15446"/>
<dbReference type="ProteomicsDB" id="48675">
<molecule id="O15446-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="48676">
<molecule id="O15446-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="17932">
<property type="antibodies" value="283 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="10849"/>
<dbReference type="Ensembl" id="ENST00000309424">
<molecule id="O15446-1"/>
<property type="protein sequence ID" value="ENSP00000310966"/>
<property type="gene ID" value="ENSG00000117877"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000589804">
<molecule id="O15446-2"/>
<property type="protein sequence ID" value="ENSP00000465099"/>
<property type="gene ID" value="ENSG00000117877"/>
</dbReference>
<dbReference type="GeneID" id="10849"/>
<dbReference type="KEGG" id="hsa:10849"/>
<dbReference type="UCSC" id="uc002pbq.1">
<molecule id="O15446-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="10849"/>
<dbReference type="DisGeNET" id="10849"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000117877.10"/>
<dbReference type="GeneCards" id="CD3EAP"/>
<dbReference type="HGNC" id="HGNC:24219">
<property type="gene designation" value="POLR1G"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000117877">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="107325">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O15446"/>
<dbReference type="OpenTargets" id="ENSG00000117877"/>
<dbReference type="PharmGKB" id="PA142672156"/>
<dbReference type="eggNOG" id="ENOG502S2W3">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00450000040362"/>
<dbReference type="HOGENOM" id="CLU_035235_0_0_1"/>
<dbReference type="InParanoid" id="O15446"/>
<dbReference type="OMA" id="FCAFGGS"/>
<dbReference type="OrthoDB" id="984661at2759"/>
<dbReference type="PhylomeDB" id="O15446"/>
<dbReference type="TreeFam" id="TF338162"/>
<dbReference type="PathwayCommons" id="O15446"/>
<dbReference type="Reactome" id="R-HSA-427413">
<property type="pathway name" value="NoRC negatively regulates rRNA expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5250924">
<property type="pathway name" value="B-WICH complex positively regulates rRNA expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-73762">
<property type="pathway name" value="RNA Polymerase I Transcription Initiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-73772">
<property type="pathway name" value="RNA Polymerase I Promoter Escape"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-73863">
<property type="pathway name" value="RNA Polymerase I Transcription Termination"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="10849">
<property type="hits" value="273 hits in 872 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="CD3EAP">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="CD3EAP"/>
<dbReference type="GenomeRNAi" id="10849"/>
<dbReference type="Pharos" id="O15446">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:O15446"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="RNAct" id="O15446">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000117877">
<property type="expression patterns" value="Expressed in testis and 202 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O15446">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O15446">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005694">
<property type="term" value="C:chromosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0001650">
<property type="term" value="C:fibrillar center"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005736">
<property type="term" value="C:RNA polymerase I complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000120">
<property type="term" value="C:RNA polymerase I transcription regulator complex"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0003899">
<property type="term" value="F:DNA-directed 5'-3' RNA polymerase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045815">
<property type="term" value="P:positive regulation of gene expression, epigenetic"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0009303">
<property type="term" value="P:rRNA transcription"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006363">
<property type="term" value="P:termination of RNA polymerase I transcription"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006362">
<property type="term" value="P:transcription elongation from RNA polymerase I promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006361">
<property type="term" value="P:transcription initiation from RNA polymerase I promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007169">
<property type="term" value="P:transmembrane receptor protein tyrosine kinase signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="InterPro" id="IPR013240">
<property type="entry name" value="DNA-dir_RNA_pol1_su_RPA34"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR15484">
<property type="entry name" value="PTHR15484"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08208">
<property type="entry name" value="RNA_polI_A34"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0240">DNA-directed RNA polymerase</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="DNA-directed RNA polymerase I subunit RPA34" id="PRO_0000228120">
<location>
<begin position="1"/>
<end position="510"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Lys">
<location>
<begin position="174"/>
<end position="177"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Lys">
<location>
<begin position="212"/>
<end position="217"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Lys">
<location>
<begin position="422"/>
<end position="428"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="504"/>
<end position="508"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="3 7">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="27"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="17">
<location>
<position position="80"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 8">
<location>
<position position="128"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 4 6 8">
<location>
<position position="136"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 5 8">
<location>
<position position="172"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="205"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 5 8">
<location>
<position position="285"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="2 8">
<location>
<position position="287"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="309"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="490"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="9">
<location>
<position position="270"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="10 11 12 13">
<location>
<position position="270"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="9">
<location>
<position position="314"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="10 11 13">
<location>
<position position="314"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_017673" evidence="19">
<original>G</original>
<variation>GGE</variation>
<location>
<position position="7"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs735482." id="VAR_051875">
<original>K</original>
<variation>T</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3212989." id="VAR_051876">
<original>T</original>
<variation>A</variation>
<location>
<position position="282"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs762562." id="VAR_051877">
<original>K</original>
<variation>E</variation>
<location>
<position position="373"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2336219." id="VAR_051878">
<original>D</original>
<variation>N</variation>
<location>
<position position="394"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3212986." id="VAR_051879">
<original>K</original>
<variation>Q</variation>
<location>
<position position="503"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3212986." id="VAR_051880" evidence="16">
<original>Q</original>
<variation>K</variation>
<location>
<position position="504"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAH54044." ref="3" evidence="22">
<original>N</original>
<variation>K</variation>
<location>
<position position="218"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAI08890." ref="3" evidence="22">
<location>
<position position="422"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17525332"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000250"/>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10373416"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16809778"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9426281"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10373416"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="16809778"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9426281"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000305"/>
<evidence key="23" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="16809778"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:24219"/>
</source>
</evidence>
<sequence length="510" mass="54986" checksum="D460FB944412D393" modified="1998-01-01" version="1">MEEPQAGDAARFSCPPNFTAKPPASESPRFSLEALTGPDTELWLIQAPADFAPECFNGRHVPLSGSQIVKGKLAGKRHRYRVLSSCPQAGEATLLAPSTEAGGGLTCASAPQGTLRILEGPQQSLSGSPLQPIPASPPPQIPPGLRPRFCAFGGNPPVTGPRSALAPNLLTSGKKKKEMQVTEAPVTQEAVNGHGALEVDMALGSPEMDVRKKKKKKNQQLKEPEAAGPVGTEPTVETLEPLGVLFPSTTKKRKKPKGKETFEPEDKTVKQEQINTEPLEDTVLSPTKKRKRQKGTEGMEPEEGVTVESQPQVKVEPLEEAIPLPPTKKRKKEKGQMAMMEPGTEAMEPVEPEMKPLESPGGTMAPQQPEGAKPQAQAALAAPKKKTKKEKQQDATVEPETEVVGPELPDDLEPQAAPTSTKKKKKKKERGHTVTEPIQPLEPELPGEGQPEARATPGSTKKRKKQSQESRMPETVPQEEMPGPPLNSESGEEAPTGRDKKRKQQQQQPV</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

